The focus of the current report, after identifying ILC3s/T cells as a major source of IL-22 during colitis, was to target AhR deletion in these specific cell types, assess IL-22 production, and determine how this impacted Bacteroides abundance in the gut during colitis. This evidence concerns the gene IL22 and colitis.